{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:13:08Z","timestamp":1761156788840,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K20731"],"award-info":[{"award-number":["19K20731"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00228-019-02794-y","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T08:02:59Z","timestamp":1575964979000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-9604","authenticated-orcid":false,"given":"Yoshihiro","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Sugioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisa","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Tachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Teramachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"2794_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1532-5415.2008.01597.x","volume":"56","author":"S Teramoto","year":"2008","unstructured":"Teramoto S, Fukuchi Y, Sasaki H, Sato K, Sekizawa K, Matsuse T, Japanese Study Group on Aspiration Pulmonary Disease (2008) Japanese study group on aspiration pulmonary disease. High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc 56:577\u2013579","journal-title":"J Am Geriatr Soc"},{"key":"2794_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(95)92638-0","volume":"345","author":"T Nakagawa","year":"1995","unstructured":"Nakagawa T, Ohrui T, Sekizawa K et al (1995) Sputum substance P in aspiration pneumonia. Lancet 345:1447","journal-title":"Lancet"},{"key":"2794_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1378\/chest.113.5.1425","volume":"113","author":"K Nakayama","year":"1998","unstructured":"Nakayama K, Sekizawa K, Sasaki H (1998) ACE inhibitor and swallowing reflex. Chest 113:1425","journal-title":"Chest"},{"key":"2794_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0140-6736(05)60114-6","volume":"352","author":"K Sekizawa","year":"1998","unstructured":"Sekizawa K, Matsui T, Nakagawa T et al (1998) ACE inhibitor and pneumonia. Lancet 352:1069","journal-title":"Lancet"},{"key":"2794_CR5","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0895-7061(99)00035-7","volume":"12","author":"K Okaishi","year":"1999","unstructured":"Okaishi K, Morimoto S, Fukuo K, Niinobu T, Hata S, Onishi T, Ogihara T (1999) Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 12:778\u2013783","journal-title":"Am J Hypertens"},{"key":"2794_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0167-4838(97)00134-9","volume":"1343","author":"DF Cunningham","year":"1997","unstructured":"Cunningham DF, O'Connor B (1997) Proline specific peptidases. Biochim Biophys Acta 1343:160\u2013186","journal-title":"Biochim Biophys Acta"},{"key":"2794_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","volume":"54","author":"NJ Brown","year":"2009","unstructured":"Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA (2009) Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 54:516\u2013523","journal-title":"Hypertension"},{"key":"2794_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1196\/annals.1372.039","volume":"1084","author":"K Alexandraki","year":"2006","unstructured":"Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A (2006) Inflammatory process in type 2 diabetes: the role of cytokines. Ann N Y Acad Sci 1084:89\u2013117","journal-title":"Ann N Y Acad Sci"},{"key":"2794_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1196\/annals.1423.042","volume":"1110","author":"D Reinhold","year":"2007","unstructured":"Reinhold D, Biton A, Goihl A, Pieper S, Lendeckel U, Faust J, Neubert K, Bank U, T\u00e4ger M, Ansorge S, Brocke S (2007) Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses. Ann N Y Acad Sci 1110:402\u2013409","journal-title":"Ann N Y Acad Sci"},{"key":"2794_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/dc10-1771","volume":"34","author":"MJ Willemen","year":"2011","unstructured":"Willemen MJ, Mantel-Teeuwisse AK, Straus SM, Meyboom RH, Egberts TC, Leufkens HG (2011) Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase. Diabetes Care 34:369\u2013374","journal-title":"Diabetes Care"},{"key":"2794_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1060028015610123","volume":"50","author":"AK Nagel","year":"2016","unstructured":"Nagel AK, Ahmed-Sarwar N, Werner PM, Cipriano GC, van Manen R, Brown JE (2016) Dipeptidyl peptidase-4 inhibitor-associated pancreatic carcinoma: a review of the FAERS database. Ann Pharmacother 50:27\u201331","journal-title":"Ann Pharmacother"},{"key":"2794_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13300-018-0408-2","volume":"9","author":"GP Fadini","year":"2018","unstructured":"Fadini GP, Sarangdhar M, Avogaro A (2018) Pharmacovigilance evaluation of the association between DPP-4 inhibitors and heart failure: stimulated reporting and moderation by drug interactions. Diabetes Ther 9:851\u2013861","journal-title":"Diabetes Ther"},{"key":"2794_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40780-018-0109-z","volume":"4","author":"Y Noguchi","year":"2018","unstructured":"Noguchi Y, Katsuno H, Ueno A, Otsubo M, Yoshida A, Kanematsu Y, Sugita I, Esaki H, Tachi T, Tsuchiya T, Teramachi H (2018) Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database. J Pharm Health Care Sci 4:15. https:\/\/doi.org\/10.1186\/s40780-018-0109-z","journal-title":"J Pharm Health Care Sci"},{"key":"2794_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1691\/ph.2019.8972","volume":"74","author":"Y Noguchi","year":"2019","unstructured":"Noguchi Y, Toda Y, Esaki H, Matsuyama T, Tachi T, Tsuchiya T, Teramachi H (2019) Association between dipeptidyl peptidase-4 inhibitors and autoimmune disorders: data mining of the spontaneous reporting system in Japan. Pharmazie. 74:305\u2013309. https:\/\/doi.org\/10.1691\/ph.2019.8972","journal-title":"Pharmazie."},{"key":"2794_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10:483\u2013486","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2794_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11:3\u201310","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2794_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, de Freitas RM (1998) A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54:315\u2013321","journal-title":"Eur J Clin Pharmacol"},{"key":"2794_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","volume":"25","author":"A Szarfman","year":"2002","unstructured":"Szarfman A, Machado SG, O'Neill RT (2002) Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database. Drug Saf 25:381\u2013392","journal-title":"Drug Saf"},{"key":"2794_CR19","doi-asserted-by":"publisher","first-page":"e40561","DOI":"10.1371\/journal.pone.0040561","volume":"7","author":"C Wang","year":"2012","unstructured":"Wang C, Guo XJ, Xu JF, Wu C, Sun YL, Ye XF, Qian W, Ma XQ, du WM, He J (2012) Exploration of the association rules mining technique for the signal detection of adverse drug events in spontaneous reporting systems. PLoS One 7:e40561. https:\/\/doi.org\/10.1371\/journal.pone.0040561","journal-title":"PLoS One"},{"key":"2794_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fphar.2018.00197","volume":"9","author":"Y Noguchi","year":"2018","unstructured":"Noguchi Y, Ueno A, Otsubo M, Katsuno H, Sugita I, Kanematsu Y, Yoshida A, Esaki H, Tachi T, Teramachi H (2018) A new search method using association rule mining for drug-drug interaction based on spontaneous report system. Front Pharmacol 9:197. https:\/\/doi.org\/10.3389\/fphar.2018.00197","journal-title":"Front Pharmacol"},{"key":"2794_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12859-018-2137-y","volume":"19","author":"Y Noguchi","year":"2018","unstructured":"Noguchi Y, Ueno A, Otsubo M, Katsuno H, Sugita I, Kanematsu Y, Yoshida A, Esaki H, Tachi T, Teramachi H (2018) A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system. BMC Bioinformatics 19:124. https:\/\/doi.org\/10.1186\/s12859-018-2137-y","journal-title":"BMC Bioinformatics"},{"key":"2794_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3820\/jjpe.14.27","volume":"14","author":"T Fujita","year":"2009","unstructured":"Fujita T (2009) Signal detection of adverse drug reactions. Jpn J Pharmacoepidemiol 14:27\u201336","journal-title":"Jpn J Pharmacoepidemiol"},{"key":"2794_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0014-5793(78)81210-1","volume":"91","author":"E Heymann","year":"1978","unstructured":"Heymann E, Mentlein R (1978) Liver dipeptidyl aminopeptidase IV hydrolyzes substance P. FEBS Lett 91:360\u2013364","journal-title":"FEBS Lett"},{"key":"2794_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0002-9440(10)62266-3","volume":"166","author":"N Busso","year":"2005","unstructured":"Busso N, Wagtmann N, Herling C, Chobaz-P\u00e9clat V, Bischof-Delaloye A, So A, Grouzmann E (2005) Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166:433\u2013442","journal-title":"Am J Pathol"},{"key":"2794_CR25","first-page":"292","volume":"56","author":"T Anno","year":"2013","unstructured":"Anno T, Hashiramoto M, Tanabe A et al (2013) A case of type 2 diabetes mellitus associated with a drug-induced fever caused by a DPP-4 inhibitor, Sitagliptin. J Japan Diab Soc 56:292\u2013297","journal-title":"J Japan Diab Soc"},{"key":"2794_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1042\/CS20090047","volume":"118","author":"M Kirby","year":"2010","unstructured":"Kirby M, Yu DM, O'Connor S et al (2010) Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. Clin Sci 118:31\u201341","journal-title":"Clin Sci"},{"key":"2794_CR27","first-page":"333","volume":"43","author":"K Marumo","year":"2005","unstructured":"Marumo K, Homma S (2005) Role gastro-esophageal reflux (GER) and swallowing latency in aspiration pulmonary diseases. Nihon Kokyuki Gakkai Zasshi 43:333\u2013339","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2794_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2165\/00002018-200730100-00007","volume":"30","author":"A Pariente","year":"2007","unstructured":"Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N (2007) Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf 30:891\u2013898","journal-title":"Drug Saf"},{"key":"2794_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1463-1326.2010.01214.x","volume":"12","author":"M Ligueros-Saylan","year":"2010","unstructured":"Ligueros-Saylan M, Foley JE, Schweizer A, Couturier A, Kothny W (2010) An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of phase II and III clinical trials. Diabetes Obes Metab 12:495\u2013509","journal-title":"Diabetes Obes Metab"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02794-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T02:02:59Z","timestamp":1607479379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02794-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02794-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}